Sarepta would need to conduct new analyses to validate the safety of Elevidys—which has had U.S. shipments paused by the ...

Chugai Pharmaceutical Co., Ltd. ( OTCPK:CHGCF) Q2 2025 Earnings Conference Call July 24, 2025 4:00 AM ET ...

We expect Incyte Corporation INCY to surpass expectations when it reports second-quarter 2025 earnings on July 29, before the ...

Wall Street analysts warn that if Sarepta Therapeutics doesn't resolve the Elevidys issues, it could jeopardize its ability to repay debt in 2027.

What happens when you stop taking Ozempic®? There’s no one-size-fits-all answer to this question. When you stop taking ...

The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to Verastem Oncology’s VS-7375.

Johnson & Johnson’s JNJ Innovative Medicine segment markets several multi-million-dollar drugs that cover a broad range of ...

Millions of patients worldwide are infected with parasitic worms. According to the World Health Organization (WHO), helminth worms are particularly common. | Immunology ...

Among reasons for the rejection, the agency cited a lack of US patient representation in the STARGLO trial assessing ...

CAN-2409 is an investigational, off-the-shelf, replication-defective adenovirus engineered to deliver the herpes simplex virus thymidine kinase (HSV-tk) gene to tumor cells. When administered with a ...

It's shaping up to be a big year for Boehringer Ingelheim—at least if the FDA plays ball. | Boehringer Chief Medical Officer ...

A new FDA-approved process called scrambler therapy retrains how the brain processes pain in a non-invasive way.